{"related:iVSoacmCzvoJ:scholar.google.com/&scioq=pharmaceutical+policy&hl=en&as_sdt=0,5":[{"title":"Issues in drug pricing, reimbursement, and access in China with references to other Asia‐Pacific region","url":"https://onlinelibrary.wiley.com/doi/abs/10.1111/j.1524-4733.2008.00376.x","authors":["Y Chen","Y Chen SO Schweitzer"],"year":2008,"numCitations":42,"pdf":"https://onlinelibrary.wiley.com/doi/pdf/10.1111/j.1524-4733.2008.00376.x","citationUrl":"http://scholar.google.com/scholar?cites=18072526156257055881&as_sdt=2005&sciodt=0,5&hl=en&scioq=pharmaceutical+policy","relatedUrl":"http://scholar.google.com/scholar?q=related:iVSoacmCzvoJ:scholar.google.com/&scioq=pharmaceutical+policy&hl=en&as_sdt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=18072526156257055881&hl=en&as_sdt=0,5&scioq=pharmaceutical+policy","publication":"Wiley Online Library","p":1,"exp":1596876810205},{"title":"Changes in use of antidiabetic medications following price regulations in C hina (1999–2009)","url":"https://onlinelibrary.wiley.com/doi/abs/10.1111/jphs.12007","authors":["CY Lu","CY Lu D Ross‐Degnan","CY Lu D Ross‐Degnan P Stephens…"],"year":2013,"numCitations":18,"pdf":"http://38.95.176.53/icium2011/ConferenceMaterials/878-lu-_a.pdf","citationUrl":"http://scholar.google.com/scholar?cites=16186460231445663691&as_sdt=2005&sciodt=0,5&hl=en&scioq=pharmaceutical+policy","relatedUrl":"http://scholar.google.com/scholar?q=related:y09OKtLboeAJ:scholar.google.com/&scioq=pharmaceutical+policy&hl=en&as_sdt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=16186460231445663691&hl=en&as_sdt=0,5&scioq=pharmaceutical+policy","publication":"Wiley Online Library"},{"title":"Does perverse economic incentive lead to the irrational uses of medicines?","url":"https://www.tandfonline.com/doi/full/10.1586/14737167.2013.856266","authors":["W Mao","W Mao S Tang","W Mao S Tang W Chen"],"year":2013,"numCitations":14,"pdf":"https://www.tandfonline.com/doi/full/10.1586/14737167.2013.856266","citationUrl":"http://scholar.google.com/scholar?cites=448011323382459992&as_sdt=2005&sciodt=0,5&hl=en&scioq=pharmaceutical+policy","relatedUrl":"http://scholar.google.com/scholar?q=related:WG6QyeynNwYJ:scholar.google.com/&scioq=pharmaceutical+policy&hl=en&as_sdt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=448011323382459992&hl=en&as_sdt=0,5&scioq=pharmaceutical+policy","publication":"Taylor & Francis"},{"title":"A price and use comparison of generic versus originator cardiovascular medicines: a hospital study in Chongqing, China","url":"https://link.springer.com/article/10.1186/1472-6963-13-390","authors":["W Zeng"],"year":2013,"numCitations":25,"pdf":"https://link.springer.com/article/10.1186/1472-6963-13-390","citationUrl":"http://scholar.google.com/scholar?cites=12346681315180647354&as_sdt=2005&sciodt=0,5&hl=en&scioq=pharmaceutical+policy","relatedUrl":"http://scholar.google.com/scholar?q=related:upNLmj05WKsJ:scholar.google.com/&scioq=pharmaceutical+policy&hl=en&as_sdt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=12346681315180647354&hl=en&as_sdt=0,5&scioq=pharmaceutical+policy","publication":"Springer"},{"title":"International experiences of promoting generics use and its implications to China","url":"https://onlinelibrary.wiley.com/doi/abs/10.1111/jebm.12030","authors":["J Sun"],"year":2013,"numCitations":11,"pdf":"http://citeseerx.ist.psu.edu/viewdoc/download?doi=10.1.1.900.4215&rep=rep1&type=pdf","citationUrl":"http://scholar.google.com/scholar?cites=8911345833271156332&as_sdt=2005&sciodt=0,5&hl=en&scioq=pharmaceutical+policy","relatedUrl":"http://scholar.google.com/scholar?q=related:bN7ILtJ1q3sJ:scholar.google.com/&scioq=pharmaceutical+policy&hl=en&as_sdt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=8911345833271156332&hl=en&as_sdt=0,5&scioq=pharmaceutical+policy","publication":"Wiley Online Library"},{"title":"从国际视角看我国的药品定价, 补偿和可及性问题","url":"http://www.cqvip.com/qk/90642x/200705/24428603.html","authors":["陈英耀"],"year":2007,"numCitations":7,"citationUrl":"http://scholar.google.com/scholar?cites=3828674080392767034&as_sdt=2005&sciodt=0,5&hl=en&scioq=pharmaceutical+policy","relatedUrl":"http://scholar.google.com/scholar?q=related:OmaOesouIjUJ:scholar.google.com/&scioq=pharmaceutical+policy&hl=en&as_sdt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=3828674080392767034&hl=en&as_sdt=0,5&scioq=pharmaceutical+policy","publication":"cqvip.com"},{"title":"Review of the use of defined daily dose concept in drug utilisation research in China","url":"https://onlinelibrary.wiley.com/doi/abs/10.1002/pds.3240","authors":["L Teng","L Teng H Xin","L Teng H Xin HS Blix","L Teng H Xin HS Blix K Tsutani"],"year":2012,"numCitations":26,"pdf":"http://www.f.u-tokyo.ac.jp/~uthta/paper2/2012_Lida%20Review.pdf","citationUrl":"http://scholar.google.com/scholar?cites=3788948119540756930&as_sdt=2005&sciodt=0,5&hl=en&scioq=pharmaceutical+policy","relatedUrl":"http://scholar.google.com/scholar?q=related:wnGccT0MlTQJ:scholar.google.com/&scioq=pharmaceutical+policy&hl=en&as_sdt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=3788948119540756930&hl=en&as_sdt=0,5&scioq=pharmaceutical+policy","publication":"Wiley Online Library"},{"title":"Review of ongoing initiatives to improve prescribing efficiency in China; angiotensin receptor blockers as a case history","url":"https://www.tandfonline.com/doi/abs/10.1586/14737167.2015.963557","authors":["W Zeng","W Zeng LL Gustafsson","W Zeng LL Gustafsson M Bennie…"],"year":2015,"numCitations":6,"pdf":"https://strathprints.strath.ac.uk/53936/1/Zeng_etal_ERP2015_initiatives_to_improve_prescribing_efficiency_in_china.pdf","citationUrl":"http://scholar.google.com/scholar?cites=10042988688370402291&as_sdt=2005&sciodt=0,5&hl=en&scioq=pharmaceutical+policy","relatedUrl":"http://scholar.google.com/scholar?q=related:84OVhQDdX4sJ:scholar.google.com/&scioq=pharmaceutical+policy&hl=en&as_sdt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=10042988688370402291&hl=en&as_sdt=0,5&scioq=pharmaceutical+policy","publication":"Taylor & Francis"},{"title":"Ongoing initiatives to improve prescribing efficiency in China: statins as a case history","url":"https://strathprints.strath.ac.uk/id/eprint/52952","authors":["W Zeng","W Zeng H Xi","W Zeng H Xi B Godman…"],"year":2014,"numCitations":8,"pdf":"https://strathprints.strath.ac.uk/52952/1/Zeng_etal_GABI_2014_Ongoing_initiatives_to_improve_prescribing_efficiency_in_China.pdf","citationUrl":"http://scholar.google.com/scholar?cites=6840816129416007908&as_sdt=2005&sciodt=0,5&hl=en&scioq=pharmaceutical+policy","relatedUrl":"http://scholar.google.com/scholar?q=related:5JCahwZ2714J:scholar.google.com/&scioq=pharmaceutical+policy&hl=en&as_sdt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=6840816129416007908&hl=en&as_sdt=0,5&scioq=pharmaceutical+policy","publication":"strathprints.strath.ac.uk"}]}